|
1
|
Wei RL, Teng HJ, Yin B, Xu Y, Du Y, He FP,
Chu KT, Luo BY and Zheng GQ: A systematic review and meta-analysis
of buyang huanwu decoction in animal model of focal cerebral
ischemia. Evid Based Complement Alternat Med. 2013:1384842013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang L and Jiang DM: Neuroprotective
effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion
injury in rats is linked with inhibition of cyclin-dependent kinase
5. BMC Complement Altern Med. 13:309–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li XM, Bai XC, Qin LN, Huang H, Xiao ZJ
and Gao TM: Neuroprotective effects of Buyang Huanwu Decoction on
neuronal injury in hippocampus after transient forebrain ischemia
in rats. Neurosci Lett. 346:29–32. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang S, Gao Q, Xing S, Feng X, Peng L,
Dong H, Bao L, Zhang J, Hu Y, Li G, et al: Neuroprotective effects
of Buyang Huanwu decoction against hydrogen peroxide induced
oxidative injury in Schwann cells. J Ethnopharmacol. 137:1095–1101.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai G, Liu B, Liu W, Tan X, Rong J, Chen
X, Tong L and Shen J: Buyang Huanwu Decoction can improve recovery
of neurological function, reduce infarction volume, stimulate
neural proliferation and modulate VEGF and Flk1 expressions in
transient focal cerebral ischaemic rat brains. J Ethnopharmacol.
113:292–299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao LD, Wang JH, Jin GR, Zhao Y and Zhang
HJ: Neuroprotective effect of Buyang Huanwu decoction against focal
cerebral ischemia/reperfusion injury in rats - time window and
mechanism. J Ethnopharmacol. 140:339–344. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang L, Huang Y, Wu J, Lv G, Zhou L and
Jia J: Effect of Buyang Huanwu decoction on amino acid content in
cerebrospinal fluid of rats during ischemic/reperfusion injury. J
Pharm Biomed Anal. 86:143–150. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kostandy BB: The role of glutamate in
neuronal ischemic injury: The role of spark in fire. Neurol Sci.
33:223–237. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Robinson MB: The family of
sodium-dependent glutamate transporters: A focus on the GLT-1/EAAT2
subtype. Neurochem Int. 33:479–491. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gong SJ, Chen LY, Zhang M, Gong JX, Ma YX,
Zhang JM, Wang YJ, Hu YY, Sun XC, Li WB, et al: Intermittent
hypobaric hypoxia preconditioning induced brain ischemic tolerance
by up-regulating glial glutamate transporter-1 in rats. Neurochem
Res. 37:527–537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang W, Miao Y, Zhou S, Wang B, Luo Q and
Qiu Y: Involvement of glutamate transporter-1 in neuroprotection
against global brain ischemia-reperfusion injury induced by
postconditioning in rats. Int J Mol Sci. 11:4407–4416. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rothstein JD, Patel S, Regan MR, Haenggeli
C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung
DS, et al: Beta-lactam antibiotics offer neuroprotection by
increasing glutamate transporter expression. Nature. 433:73–77.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou J, Wang YX, Dou FF, Lü HZ, Ma ZW, Lu
PH and Xu XM: Glutamine synthetase down-regulation reduces
astrocyte protection against glutamate excitotoxicity to neurons.
Neurochem Int. 56:577–584. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee A, Lingwood BE, Bjorkman ST, Miller
SM, Poronnik P, Barnett NL, Colditz P and Pow DV: Rapid loss of
glutamine synthetase from astrocytes in response to hypoxia:
Implications for excitotoxicity. J Chem Neuroanat. 39:211–220.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Figiel M and Engele J: Pituitary adenylate
cyclase-activating polypeptide (PACAP), a neuron-derived peptide
regulating glial glutamate transport and metabolism. J Neurosci.
20:3596–3605. 2000.PubMed/NCBI
|
|
16
|
Reglodi D, Somogyvari-Vigh A, Vigh S,
Maderdrut JL and Arimura A: Neuroprotective effects of PACAP38 in a
rat model of transient focal ischemia under various experimental
conditions. Ann NY Acad Sci. 921:119–128. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen A, Wang H, Zhang J, Wu X, Liao J, Li
H, Cai W, Luo X and Ju G: BYHWD rescues axotomized neurons and
promotes functional recovery after spinal cord injury in rats. J
Ethnopharmacol. 117:451–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ding W, Zhou L, Liu W, Guan L, Li X, Liu
H, Yan F, Xu J, Zeng W and Qiu M: Opposite effects of the gap
junction blocker octanol on focal cerebral ischemia occluded for
different durations. Mol Med Rep. 9:2485–2490. 2014.PubMed/NCBI
|
|
19
|
Vaudry D, Gonzalez BJ, Basille M, Fournier
A and Vaudry H: Neurotrophic activity of pituitary adenylate
cyclase-activating polypeptide on rat cerebellar cortex during
development. Proc Natl Acad Sci USA. 96:9415–9420. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen YD, Zhou ZG, Wang Z, Gao HK, Yan WW,
Wang C, Zhao GP and Peng XH: Pituitary adenylate cyclase
activating-peptide and its receptor antagonists in development of
acute pancreatitis in rats. World J Gastroenterol. 11:538–544.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee SG, Su ZZ, Emdad L, Gupta P, Sarkar D,
Borjabad A, Volsky DJ and Fisher PB: Mechanism of ceftriaxone
induction of excitatory amino acid transporter-2 expression and
glutamate uptake in primary human astrocytes. J Biol Chem.
283:13116–13123. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lo JC, Huang WC, Chou YC, Tseng CH, Lee WL
and Sun SH: Activation of P2X(7) receptors decreases glutamate
uptake and glutamine synthetase activity in RBA-2 astrocytes via
distinct mechanisms. J Neurochem. 105:151–164. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li YK, Wang F, Wang W, Luo Y, Wu PF, Xiao
JL, Hu ZL, Jin Y, Hu G and Chen JG: Aquaporin-4 deficiency impairs
synaptic plasticity and associative fear memory in the lateral
amygdala: Involvement of downregulation of glutamate transporter-1
expression. Neuropsychopharmacology. 37:1867–1878. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ramos KM, Lewis MT, Morgan KN, Crysdale
NY, Kroll JL, Taylor FR, Harrison JA, Sloane EM, Maier SF and
Watkins LR: Spinal upregulation of glutamate transporter GLT-1 by
ceftriaxone: Therapeutic efficacy in a range of experimental
nervous system disorders. Neuroscience. 169:1888–1900. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goodrich GS, Kabakov AY, Hameed MQ, Dhamne
SC, Rosenberg PA and Rotenberg A: Ceftriaxone treatment after
traumatic brain injury restores expression of the glutamate
transporter, GLT-1, reduces regional gliosis, and reduces
post-traumatic seizures in the rat. J Neurotrauma. 30:1434–1441.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kruchkova Y, Ben-Dror I, Herschkovitz A,
David M, Yayon A and Vardimon L: Basic fibroblast growth factor: A
potential inhibitor of glutamine synthetase expression in injured
neural tissue. J Neurochem. 77:1641–1649. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rossi DJ, Brady JD and Mohr C: Astrocyte
metabolism and signaling during brain ischemia. Nat Neurosci.
10:1377–1386. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Y and Rempe DA: Targeting astrocytes
for stroke therapy. Neurotherapeutics. 7:439–451. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gegelashvili G, Robinson MB, Trotti D and
Rauen T: Regulation of glutamate transporters in health and
disease. Prog Brain Res. 132:267–286. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Trotti D, Aoki M, Pasinelli P, Berger UV,
Danbolt NC, Brown RH Jr and Hediger MA: Amyotrophic lateral
sclerosis-linked glutamate transporter mutant has impaired
glutamate clearance capacity. J Biol Chem. 276:576–582.
2001.PubMed/NCBI
|
